These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35099277)

  • 1. Delays in Continuous Glucose Monitoring Device Initiation: A Single Center Experience and a Call to Change.
    Modzelewski KL; Murati J; Charoenngam N; Rehm C; Steenkamp DW
    Diabetes Technol Ther; 2022 Jun; 24(6):390-395. PubMed ID: 35099277
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus.
    Gurnurkar S; Owens L; Chalise S; Vyas N
    J Pediatr Endocrinol Metab; 2021 Mar; 34(3):311-317. PubMed ID: 33618445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates and Correlates of Uptake of Continuous Glucose Monitors Among Adults with Type 2 Diabetes in Primary Care and Endocrinology Settings.
    Mayberry LS; Guy C; Hendrickson CD; McCoy AB; Elasy T
    J Gen Intern Med; 2023 Aug; 38(11):2546-2552. PubMed ID: 37254011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study.
    Champakanath A; Akturk HK; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Care; 2022 Mar; 45(3):750-753. PubMed ID: 35018417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes.
    Ulrich H; Bowen M
    J Am Pharm Assoc (2003); 2021; 61(6):e76-e82. PubMed ID: 34154906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous glucose monitoring for primary care patients with diabetes: Barriers, facilitators, & resources to support access.
    Warman M; Fillippi M; Manning B; Oser T; Nease D; Hall T; Oser S; Carroll J
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36857171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes.
    McGill DE; Volkening LK; Butler DA; Harrington KR; Katz ML; Laffel LM
    Diabetes Technol Ther; 2018 Jun; 20(6):434-439. PubMed ID: 29727245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study.
    Sheikh K; Bartz SK; Lyons SK; DeSalvo DJ
    J Diabetes Res; 2018; 2018():5162162. PubMed ID: 30151393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation.
    Kesavadev J; Vigersky R; Shin J; Pillai PBS; Shankar A; Sanal G; Krishnan G; Jothydev S
    Adv Ther; 2017 Aug; 34(8):1918-1927. PubMed ID: 28667580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes Technology Use in Remote Pediatric Patients with Type 1 Diabetes Using Clinic-to-Clinic Telemedicine.
    Cobry EC; Reznick-Lipina T; Pyle L; Slover R; Thomas JF; Alonso GT; Wadwa RP
    Diabetes Technol Ther; 2022 Jan; 24(1):67-74. PubMed ID: 34524007
    [No Abstract]   [Full Text] [Related]  

  • 18. Motivational Stage at Continuous Glucose Monitoring (CGM) Initiation in Pediatric Type 1 Diabetes Is Associated With Current Glycemic Control but Does Not Predict Future CGM Adherence or Glycemic Control.
    Verbeeten KC; Chan J; Sourial N; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Cooper T; Richardson C; Lawson ML; ;
    Can J Diabetes; 2021 Jul; 45(5):466-472.e4. PubMed ID: 34176610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Personal Continuous Glucose Monitoring Device Is Associated With Reduced Risk of Hypoglycemia in a 16-Week Clinical Trial of People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Jensen MH; Vestergaard P; Hirsch IB; Hejlesen O
    J Diabetes Sci Technol; 2022 Jan; 16(1):106-112. PubMed ID: 32945187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.